The UK private GP EHR market is set to grow due to increased demand for medical services in the private sector and technological advances in healthcare. A spike in Google searches for private GPs indicates a 156% rise from 2019 to 2022. Despite potential limitations like cyber threats and technical issues, the integration of EHR with AI and wearable technology, and the need for secure patient data storage, will likely boost the market.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
